The Iliac/SFA/Popliteal Center

Filter Your Results




Complex Chronic Total Occlusion Treatment Using a Re-Entry Catheter

Tony S. Das, MD

September 2006—A creative approach utilizing retrograde re-entry from the popliteal artery to the proximal SFA.

A Different Approach

Robert M. Bersin, MD

September 2006—Employing a bidirectional technique for treating an iliac CTO.

SFA Revascularization Using the Viabahn Endoprosthesis

Richard D. Coats, MD; John G. Adams, Jr, MD; and Paul W. Humphrey, MD

September 2006—Technical considerations from a challenging case.

Improving Quality of Life

David E. Allie, MD; Chris J. Hebert, RT(R), R-CIS; Raghotham Patlola, MD; and Craig M. Walker, MD

September 2006—The legs, the heart, and sex: What is the connection? An iliac artery case report.

Treating Complex Femoropopliteal Lesions

Takao Ohki, MD, PhD

September 2006—A case presentation showing how modern endovascular tools can facilitate optimal treatment.

Laser Treatment

Robert Gallino, MD

September 2006—Using the Spectranetics Turbo catheter to treat a calcified lesion and a thrombotic occlusion in the SFA

An Interview With Mark W. Mewissen, MD

Mark W. Mewissen, MD

July 2006—A renowned vascular radiologist shares his wisdom about the state of the practice, SFA stenting, and online education.

Stent Fracture Resistance of a Cobalt Chromium Stent

Mahmood K. Razavi, MD; Alexander Nikanorov, MD, PhD; H. Bob Smouse, MD; Hao-Ming Hsiao, PhD; and Michael D. Dake, MD

May 2006—Comparative studies are necessary to examine various devices' performance in the renal arteries.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.